Skip to main content
. 2023 Jul 22;26(8):107375. doi: 10.1016/j.isci.2023.107375

Figure 6.

Figure 6

Overexpressing SIRT3 plus PARP inhibition with olaparib fully restores hexokinase activity in quadriceps of AR100Q mice

Levels of Hexokinase in quadriceps from WT, AR100Q, and AR100Q-SIRT3 male mice (n = 3) at age 11 weeks fed no-drug compounded or olaparib-compounded food. All statistical analysis show mean ± SD, and used a two-way ANOVA and Tukey’s post-hoc (∗∗∗ = p ≤ 0.001). WT, wild type; SIRT3, SIRT3-flag overexpression; AR100Q, polyQ-expanded AR; AR100Q-SIRT3, polyQ-expanded AR with SIRT3-flag overexpression; olaparib, PARP inhibitor (1150 g of olaparib in 1 kg of feed).